XML 19 R5.htm IDEA: XBRL DOCUMENT v3.19.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common stock
Additional paid-in capital
Accumulated Other Comprehensive Loss
Accumulated deficit
Private Financing
Private Financing
Common stock
Private Financing
Additional paid-in capital
Public Offering
Public Offering
Common stock
Public Offering
Additional paid-in capital
At-the-market Offering
At-the-market Offering
Common stock
At-the-market Offering
Additional paid-in capital
Private placement
Private placement
Common stock
Private placement
Additional paid-in capital
Redeemable Convertible Preferred Stock [Member]
Beginning balance (in shares) at Dec. 31, 2016   833,744                                
Beginning balance at Dec. 31, 2016 $ (61,921) $ 8 $ 5,147   $ (67,076)                          
Beginning balance (in shares) at Dec. 31, 2016                                   18,584,390
Beginning balance at Dec. 31, 2016                                   $ 76,976
Increase (Decrease) in Temporary Equity [Roll Forward]                                    
Accretion of redeemable convertible preferred stock to redemption value                                   $ 5
Conversion of preferred stock to common stock (in shares)                                   (18,584,390)
Conversion of preferred stock to common stock                                   $ (76,981)
Ending balance (in shares) at Feb. 13, 2017                                   0
Ending balance at Feb. 13, 2017                                   $ 0
Beginning balance (in shares) at Dec. 31, 2016   833,744                                
Beginning balance at Dec. 31, 2016 (61,921) $ 8 5,147   (67,076)                          
Stockholders’ deficit                                    
Issuance of common stock in public offering, net of issuance cost (in shares)             6,359,628           840,534          
Issuance of common stock in public offering, net of issuance cost           $ 39,156 $ 64 $ 39,092       $ 7,603 $ 8 $ 7,595        
Accretion of redeemable convertible preferred stock to redemption value (5)       (5)                          
Issuance of common stock upon reverse merger (in shares)   1,024,960                                
Issuance of common stock upon reverse merger 204 $ 10 194                              
Reclassification of warrant liability to equity 51   51                              
Issuance of common stock upon cashless exercise of warrant (in shares)   16,387                                
Shares issued for cash upon the exercise of stock options (in shares)   412,894                                
Shares issued for cash upon the exercise of stock options 307 $ 5 302                              
Issuance of common stock for cash under employee stock purchase plan (in shares)   13,193                                
Issuance of common stock for cash under employee stock purchase plan 110   110                              
Issuance of warrant classified as equity 127   127                              
Share-based compensation expense 2,409   2,409                              
Change in unrealized loss on investments 0                                  
Net loss $ (26,512)       (26,512)                          
Ending balance (in shares) at Dec. 31, 2017 22,568,006 22,568,006                                
Ending balance at Dec. 31, 2017 $ 38,510 $ 226 131,877 $ 0 (93,593)                          
Beginning balance (in shares) at Dec. 31, 2016                                   18,584,390
Beginning balance at Dec. 31, 2016                                   $ 76,976
Increase (Decrease) in Temporary Equity [Roll Forward]                                    
Accretion of redeemable convertible preferred stock to redemption value                                   $ 5
Conversion of preferred stock to common stock (in shares)   13,066,666                               (18,584,390)
Conversion of preferred stock to common stock 76,981 $ 131 76,850                             $ (76,981)
Ending balance (in shares) at Feb. 13, 2017                                   0
Ending balance at Feb. 13, 2017                                   $ 0
Stockholders’ deficit                                    
Issuance of common stock in public offering, net of issuance cost (in shares)                   7,414,996     372,852     150,987    
Issuance of common stock in public offering, net of issuance cost                 $ 37,845 $ 74 $ 37,771 $ 2,657 $ 4 $ 2,653 $ 935 $ 2 $ 933  
Shares issued for cash upon the exercise of stock options (in shares)   280,178                                
Shares issued for cash upon the exercise of stock options 182 $ 2 180                              
Issuance of common stock for cash under employee stock purchase plan (in shares)   52,444                                
Issuance of common stock for cash under employee stock purchase plan 242   242                              
Issuance of warrant classified as equity 0                                  
Share-based compensation expense 3,679   3,679                              
Change in unrealized loss on investments (3)     (3)                            
Net loss $ (32,703)       (32,703)                          
Ending balance (in shares) at Dec. 31, 2018 30,839,463 30,839,463                                
Ending balance at Dec. 31, 2018 $ 51,344 $ 308 $ 177,335 $ (3) $ (126,296)                          
Increase (Decrease) in Temporary Equity [Roll Forward]                                    
Conversion of preferred stock to common stock $ 0